Viewing Study NCT02678260


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2026-03-10 @ 11:32 PM
Study NCT ID: NCT02678260
Status: COMPLETED
Last Update Posted: 2018-06-08
First Post: 2016-01-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of PDR001 in Patients With Advanced Malignancies.
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced malignancies View
None PDR001 View
None Japanese patients View
None adults View